Video
Kenya launches long-acting Lenacapavir in bid to strengthen HIV prevention: Video
Kenya has introduced the long-acting injectable Lenacapavir for HIV prevention, a move health officials describe as a turning point in the country’s fight against HIV and a step toward greater health independence across Africa.
The rollout comes after Kenya’s health sector faced financial strain following funding cuts by the United States Agency for International Development. In December, a Kenyan court also suspended a $2.5 billion health agreement with the United States over data-privacy concerns, further complicating support for health programmes.
This story is written and edited by the Global South World team, you can contact us here.
